TD Private Client Wealth LLC cut its holdings in shares of Crown Holdings, Inc. (NYSE:CCK – Free Report) by 6.8% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,739 shares of the industrial products company’s stock after selling 201 shares during the quarter. TD Private Client Wealth LLC’s holdings in Crown were worth $263,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Wealth Enhancement Advisory Services LLC increased its stake in Crown by 15.0% during the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 7,156 shares of the industrial products company’s stock worth $532,000 after acquiring an additional 931 shares during the period. Swedbank AB increased its position in shares of Crown by 1.7% in the second quarter. Swedbank AB now owns 143,502 shares of the industrial products company’s stock worth $10,675,000 after purchasing an additional 2,371 shares during the period. Blue Trust Inc. raised its stake in Crown by 172.6% in the second quarter. Blue Trust Inc. now owns 608 shares of the industrial products company’s stock valued at $48,000 after purchasing an additional 385 shares in the last quarter. Nisa Investment Advisors LLC lifted its position in Crown by 6.1% during the second quarter. Nisa Investment Advisors LLC now owns 2,753 shares of the industrial products company’s stock worth $205,000 after purchasing an additional 158 shares during the period. Finally, Neo Ivy Capital Management acquired a new stake in Crown during the second quarter worth about $110,000. 90.93% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several research analysts have commented on CCK shares. Barclays boosted their price objective on shares of Crown from $100.00 to $112.00 and gave the company an “overweight” rating in a research report on Monday, October 21st. Morgan Stanley upped their price objective on Crown from $105.00 to $109.00 and gave the stock an “equal weight” rating in a research report on Monday, October 21st. Robert W. Baird raised their price objective on Crown from $100.00 to $110.00 and gave the company an “outperform” rating in a research note on Monday, October 21st. Truist Financial increased their price objective on shares of Crown from $95.00 to $103.00 and gave the company a “hold” rating in a research note on Tuesday, October 15th. Finally, Citigroup lifted their price target on Crown from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Wednesday, October 2nd. Three analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. According to MarketBeat, Crown has a consensus rating of “Moderate Buy” and a consensus price target of $106.62.
Crown Price Performance
Crown stock opened at $87.88 on Friday. The stock’s 50 day moving average price is $92.45 and its two-hundred day moving average price is $87.47. The stock has a market capitalization of $10.51 billion, a price-to-earnings ratio of 108.49, a PEG ratio of 1.95 and a beta of 0.83. The company has a debt-to-equity ratio of 2.19, a quick ratio of 0.84 and a current ratio of 1.21. Crown Holdings, Inc. has a 52-week low of $69.61 and a 52-week high of $98.46.
Crown (NYSE:CCK – Get Free Report) last posted its quarterly earnings results on Thursday, October 17th. The industrial products company reported $1.99 earnings per share for the quarter, beating the consensus estimate of $1.81 by $0.18. The firm had revenue of $3.07 billion during the quarter, compared to the consensus estimate of $3.07 billion. Crown had a net margin of 0.83% and a return on equity of 24.57%. On average, equities analysts predict that Crown Holdings, Inc. will post 6.34 earnings per share for the current year.
Crown Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, November 27th. Shareholders of record on Thursday, November 14th were paid a $0.25 dividend. The ex-dividend date was Thursday, November 14th. This represents a $1.00 dividend on an annualized basis and a yield of 1.14%. Crown’s dividend payout ratio (DPR) is presently 123.46%.
Insider Activity
In other Crown news, Director James H. Miller sold 1,006 shares of the firm’s stock in a transaction on Monday, September 23rd. The shares were sold at an average price of $95.60, for a total value of $96,173.60. Following the transaction, the director now directly owns 12,424 shares of the company’s stock, valued at approximately $1,187,734.40. This trade represents a 7.49 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Gerard H. Gifford sold 10,000 shares of the business’s stock in a transaction dated Wednesday, October 23rd. The stock was sold at an average price of $95.89, for a total transaction of $958,900.00. Following the sale, the chief operating officer now directly owns 114,402 shares of the company’s stock, valued at approximately $10,970,007.78. The trade was a 8.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 26,006 shares of company stock worth $2,478,049 over the last quarter. 0.90% of the stock is currently owned by corporate insiders.
About Crown
Crown Holdings, Inc, together with its subsidiaries, engages in the packaging business in the United States and internationally. It operates through Americas Beverage, European Beverage, Asia Pacific, and Transit Packaging segments. The company manufactures and sells recyclable aluminum beverage cans and ends, glass bottles, steel crowns, aluminum caps, non-beverage cans, and aerosol cans and closures.
Read More
- Five stocks we like better than Crown
- Best Aerospace Stocks Investing
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- How to Invest in Small Cap StocksĀ
- Texas Instruments: The Old-School Tech Titan Still Delivering
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Want to see what other hedge funds are holding CCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Crown Holdings, Inc. (NYSE:CCK – Free Report).
Receive News & Ratings for Crown Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crown and related companies with MarketBeat.com's FREE daily email newsletter.